Made a strategic investment in Feldan Therapeutics to accelerate its intracellular drug-delivery pipeline, including lead candidate FLD-103.
Feldan Therapeutics is a clinical-stage biotech company that specializes in the development of treatments based on the intracellular delivery of therapeutics
Feldan Therapeutics is a clinical-stage biotech company that specializes in the development of treatments based on the intracellular delivery of therapeutics. The company has developed the Feldan Shuttle®, a proprietary peptide-based technology that enables safe, rapid, and efficient delivery of antisense oligonucleotides (ASO) to cells.